News 18 Teams Selected for Classroom Portion of the 19th Annual Global New Venture Challenge From Chicago, Hong Kong, and London, 18 teams are advancing to the classroom portion of the Polsky Center for Entrepreneurship and Innovation’s 2026 Global New Venture Challenge (GNVC). Now...
News George Shultz Innovation Fund Announces 4 Finalists Pitching for Potential Investment The 2026 George Shultz Innovation Fund finalists are developing novel software, medical devices, and therapeutics. Managed by the Polsky Center for Entrepreneurship and Innovation, the George Shultz Innovation Fund provides up to...
News Polsky Center Announces 2026 E-Commerce Growth Blueprint Cohort The Polsky Center for Entrepreneurship and Innovation has announced the 2026 cohort for the Polsky Exchange’s E-Commerce Growth Blueprint Program, a hands-on program designed to help small businesses strengthen their...
News NVC@30 Fireside Chat with Sebastian Rivas Explores Building Andes from NVC Winner to Real Estate Asset Platform As part of the NVC@30 Fireside Chat series, the Polsky Center welcomed Sebastian Rivas, MBA ’21, founder and CEO of Andes, to discuss his entrepreneurial journey, his experience in the...
Technology Peripherally Restricted Κ-Opioid Receptor Agonist Co-Formulation For Preventing Opioid-Induced Respiratory Depression An opioid painkiller combined with a peripherally restricted κ-opioid receptor agonist stimulating the carotid body to prevent opioid-induced respiratory depression, enhancing breathing without affecting pain relief or causing central side…
Technology Novel Small Molecule Treatment for Staphylococcus Aureus SSTI Infections SUMMARY Staphylococcus aureus infects 50,000 patients and kills 20,000 annually in the United States alone. With widespread antibiotic resistance, there is an urgent need for alternative mechanisms of targeting S.…
Technology Viral RNA Modification Technique To Create Attenuated Live Vaccines For Respiratory Syncytial Virus (RSV) and Other NNS RNA Viruses A method to attenuate RSV and other NNS RNA viruses by reducing m6A modifications on their RNA. This approach enhances genetic stability, ensures sufficient attenuation, triggers higher immune responses, retains…
Technology NeuroSight ICP: AI-Assisted, Real-Time Forecasting of Intracranial Pressure Crises NeuroSight ICP is a bedside-ready, AI-assisted forecasting system designed to predict intracranial pressure (ICP) crises roughly 30 minutes before onset using continuous neuro-monitoring data. It combines interpretable statistical modeling with…
Technology Ergonomic Arm Board For Transradial Approach Catherization Procedures Cardiac catherization, or angiography, is a procedure used to gain access to a patient's arterial system, and is used to treat and diagnose many heart conditions. While the transfermoral (through…
Technology A Microbial Consortia That Depresses Klebsiella Pneumoniae Drug-resistant Enterobacteriaceae (particularly K. pneumoniae) are a growing cause of hospital-acquired infections, pneumonia, and antibiotic failure. Broad-spectrum antibiotics exacerbate dysbiosis and resistance, while fecal microbiota transplant lacks standardization, mechanistic clarity,…
Technology Use Of Bacteriophages As Antimicrobial Agents Aagainst Klebsiella Pneumoniae Klebsiella infections are a major and growing clinical threat, particularly in hospital-acquired and device-associated settings, where multidrug resistance severely limits antibiotic options. Existing antibiotics disrupt commensal microbiota, drive resistance, and…
Technology Defined Live Biotherapeutic Compositions That Restore Depleted Gut Metabolites To Improve Outcomes In Liver Disease Patients Patients with advanced liver disease, transplant recipients, and other critically ill populations frequently experience profound microbiome dysbiosis due to antibiotics and hospitalization. This dysbiosis is characterized by loss of microbial…
